The hunt for radiation biomarkers: current situation
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62690094%3A18470%2F20%3A50016194" target="_blank" >RIV/62690094:18470/20:50016194 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/60162694:G44__/20:00555431
Výsledek na webu
<a href="https://www.tandfonline.com/doi/abs/10.1080/09553002.2020.1704909?journalCode=irab20" target="_blank" >https://www.tandfonline.com/doi/abs/10.1080/09553002.2020.1704909?journalCode=irab20</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1080/09553002.2020.1704909" target="_blank" >10.1080/09553002.2020.1704909</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
The hunt for radiation biomarkers: current situation
Popis výsledku v původním jazyce
Purpose: The possibility of a large-scale acute radiation exposure necessitates the development of new methods that could provide a rapid assessment of the doses received by individuals using high-throughput technologies. There is also a great interest in developing new biomarkers of dose exposure, which could be used in large molecular epidemiological studies in order to correlate estimated doses received and health effects. The goal of this review was to summarize current literature focused on biological dosimetry, namely radiation-responsive biomarkers. Methods: The studies involved in this review were thoroughly selected according to the determined criteria and PRISMA guidelines. Results: We described briefly recent advances in radiation genomics and metabolomics, giving particular emphasis to proteomic analysis. The majority of studies were performed on animal models (rats, mice, and non-human primates). They have provided much beneficial information, but the most relevant tests have been done on human (oncological) patients. By inspecting the radiaiton biodosimetry literate of the last 10years, we identified a panel of candidate markers for each –omic approach involved. Conslusions: We reviewed different methodological approaches and various biological materials, which can be exploited for dose-effect prediction. The protein biomarkers from human plasma are ideal for this specific purpose. From a plethora of candidate markers, FDXR is a very promising transcriptomic candidate, and importantly this biomarker was also confirmed by some studies at protein level in humans.
Název v anglickém jazyce
The hunt for radiation biomarkers: current situation
Popis výsledku anglicky
Purpose: The possibility of a large-scale acute radiation exposure necessitates the development of new methods that could provide a rapid assessment of the doses received by individuals using high-throughput technologies. There is also a great interest in developing new biomarkers of dose exposure, which could be used in large molecular epidemiological studies in order to correlate estimated doses received and health effects. The goal of this review was to summarize current literature focused on biological dosimetry, namely radiation-responsive biomarkers. Methods: The studies involved in this review were thoroughly selected according to the determined criteria and PRISMA guidelines. Results: We described briefly recent advances in radiation genomics and metabolomics, giving particular emphasis to proteomic analysis. The majority of studies were performed on animal models (rats, mice, and non-human primates). They have provided much beneficial information, but the most relevant tests have been done on human (oncological) patients. By inspecting the radiaiton biodosimetry literate of the last 10years, we identified a panel of candidate markers for each –omic approach involved. Conslusions: We reviewed different methodological approaches and various biological materials, which can be exploited for dose-effect prediction. The protein biomarkers from human plasma are ideal for this specific purpose. From a plethora of candidate markers, FDXR is a very promising transcriptomic candidate, and importantly this biomarker was also confirmed by some studies at protein level in humans.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
10609 - Biochemical research methods
Návaznosti výsledku
Projekt
—
Návaznosti
S - Specificky vyzkum na vysokych skolach
Ostatní
Rok uplatnění
2020
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
International journal of radiation biology
ISSN
0955-3002
e-ISSN
—
Svazek periodika
96
Číslo periodika v rámci svazku
3
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
13
Strana od-do
370-382
Kód UT WoS článku
000516972500009
EID výsledku v databázi Scopus
2-s2.0-85077843182